These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 10683000)

  • 1. Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial.
    Vermeulen EG; Stehouwer CD; Twisk JW; van den Berg M; de Jong SC; Mackaay AJ; van Campen CM; Visser FC; Jakobs CA; Bulterjis EJ; Rauwerda JA
    Lancet; 2000 Feb; 355(9203):517-22. PubMed ID: 10683000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of homocysteine-lowering treatment with folic acid plus vitamin B on cerebrovascular atherosclerosis and white matter abnormalities as determined by MRA and MRI: a placebo-controlled, randomized trial.
    Vermeulen EG; Stehouwer CD; Valk J; van der Knaap M; van den Berg M; Twisk JW; Prevoo W; Rauwerda JA
    Eur J Clin Invest; 2004 Apr; 34(4):256-61. PubMed ID: 15086356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness: a 2-year, randomized, placebo-controlled trial.
    van Dijk RA; Rauwerda JA; Steyn M; Twisk JW; Stehouwer CD
    Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):2072-9. PubMed ID: 11742887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocysteine-lowering treatment with folic acid plus vitamin B6 lowers urinary albumin excretion but not plasma markers of endothelial function or C-reactive protein: further analysis of secondary end-points of a randomized clinical trial.
    Vermeulen EG; Rauwerda JA; van den Berg M; de Jong SC; Schalkwijk C; Twisk JW; Stehouwer CD
    Eur J Clin Invest; 2003 Mar; 33(3):209-15. PubMed ID: 12641538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normohomocysteinaemia and vitamin-treated hyperhomocysteinaemia are associated with similar risks of cardiovascular events in patients with premature peripheral arterial occlusive disease. A prospective cohort study.
    de Jong SC; Stehouwer CD; van den Berg M; Geurts TW; Bouter LM; Rauwerda JA
    J Intern Med; 1999 Jul; 246(1):87-96. PubMed ID: 10447230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia.
    van den Berg M; Franken DG; Boers GH; Blom HJ; Jakobs C; Stehouwer CD; Rauwerda JA
    J Vasc Surg; 1994 Dec; 20(6):933-40. PubMed ID: 7990188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients.
    van Guldener C; Janssen MJ; de Meer K; Donker AJ; Stehouwer CD
    J Intern Med; 1999 Feb; 245(2):175-83. PubMed ID: 10081520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hyperhomocysteinemia with folic acid and vitamins B12 and B6 attenuates thrombin generation.
    Undas A; Domagala TB; Jankowski M; Szczeklik A
    Thromb Res; 1999 Sep; 95(6):281-8. PubMed ID: 10527405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.
    Jamison RL; Hartigan P; Kaufman JS; Goldfarb DS; Warren SR; Guarino PD; Gaziano JM;
    JAMA; 2007 Sep; 298(10):1163-70. PubMed ID: 17848650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of long-term homocysteine reduction with B vitamins on arterial wall inflammation assessed by fluorodeoxyglucose positron emission tomography: a randomised double-blind, placebo-controlled trial.
    Potter K; Lenzo N; Eikelboom JW; Arnolda LF; Beer C; Hankey GJ
    Cerebrovasc Dis; 2009; 27(3):259-65. PubMed ID: 19202330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endpoints for homocysteine-lowering trials.
    Bostom AG; Garber C
    Lancet; 2000 Feb; 355(9203):511-2. PubMed ID: 10682995
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical relevance of hyperhomocysteinaemia in atherothrombotic disease.
    Stehouwer DA
    Drugs Aging; 2000 Apr; 16(4):251-60. PubMed ID: 10874520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does lowering plasma homocysteine reduce vascular disease risk?
    Miller JW
    Nutr Rev; 2001 Jul; 59(7):242-4. PubMed ID: 11475450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial.
    Mangoni AA; Sherwood RA; Swift CG; Jackson SH
    J Intern Med; 2002 Dec; 252(6):497-503. PubMed ID: 12472909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperhomocysteinemia in type 2 diabetes mellitus: cardiovascular risk factors and effect of treatment with folic acid and pyridoxine.
    Baliga BS; Reynolds T; Fink LM; Fonseca VA
    Endocr Pract; 2000; 6(6):435-41. PubMed ID: 11155214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine--relevant for atherogenesis?
    Kircher T; Sinzinger H
    Wien Klin Wochenschr; 2000 Jun; 112(12):523-32. PubMed ID: 10953870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High homocysteine, low folate, and low vitamin B6 concentrations: prevalent risk factors for vascular disease in heart transplant recipients.
    Gupta A; Moustapha A; Jacobsen DW; Goormastic M; Tuzcu EM; Hobbs R; Young J; James K; McCarthy P; van Lente F; Green R; Robinson K
    Transplantation; 1998 Feb; 65(4):544-50. PubMed ID: 9500631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hyperhomocysteinemia in renal transplant recipients. A randomized, placebo-controlled trial.
    Bostom AG; Gohh RY; Beaulieu AJ; Nadeau MR; Hume AL; Jacques PF; Selhub J; Rosenberg IH
    Ann Intern Med; 1997 Dec; 127(12):1089-92. PubMed ID: 9412311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial.
    Ebbing M; Bleie Ø; Ueland PM; Nordrehaug JE; Nilsen DW; Vollset SE; Refsum H; Pedersen EK; Nygård O
    JAMA; 2008 Aug; 300(7):795-804. PubMed ID: 18714059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normohomocysteinaemia and vitamin-treated hyperhomocysteinaemia are associated with similar risks of cardiovascular events in patients with premature atherothrombotic cerebrovascular disease. A prospective cohort study.
    Vermeulen EG; Rauwerda JA; Erix P; de Jong SC; Twisk JW; Jakobs C; Witjes RJ; Stehouwer CD
    Neth J Med; 2000 Apr; 56(4):138-46. PubMed ID: 10727759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.